News | June 06, 2022
ANI Pharmaceuticals consolidates operation post Novitium acquisition
Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023
Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
Innate to receive $5M milestone payment from AstraZeneca
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
Facility features LED lighting, solar panels, automation and innovative temperature-controlled systems to maximize efficiency and minimize environmental impact
Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Subscribe To Our Newsletter & Stay Updated
